Abstract

Objective To investigate the clinical effects of transcatheter arterial chemoembolization(TACE) and transcatheter arterial segmental chemoembolization(TASCE) on treatment of primary liver cancer.Methods Eighty patients of liver cancer after hepatitis B were selected retrospectively.Forty patients were treated with TACE and 40 patients with TASCE.Their serum levels of ALT,AST,TBil,ALB at 1 day after the surgery,1 week after the surgery,4 week after the surgery were detected.Rates of tumor shrinkage were calculated by CT a month after the surgery.Results Serum levels of ALT in TACE group one day after surgery,one week since surgery,4 weeks since surgery were (515.25 ±107.34),(196.80 ± 64.33) and (65.52 ± 10.20) U/L,and were significantly higher than those in TASCE group [(117.51±21.47),(82.13±28.31)and (58.38±8.34)U/L,separately](t =22.98,P<0.01; t =10.32,P< 0.01 ; t =3.43,P < 0.01).Serum levels of AST in TACE group one day after surgery,one week since surgery,4 weeks since surgery were (454.58 ± 83.09),(68.72 ± 8.13) and (43.62 ± 6.43) U/L,and were significantly higher than those in TASCE group[(123.51 ± 19.32),(48.68 ± 6.57) and (39.54 ± 5.12) U/L,(sep tely)] (t =24.55,P < 0.01; t =12.13,P < 0.01; t =3.14,P < 0.01).Serum levels of TBil in TACE group on the day after surgery,after a week since surgery,after 4 weeks since surgery were (51.97 ± 6.23),(35.74 ± 4.56) and (20.04 ± 3.81) μmol/L,and were significantly higher than those in TASCE group[(25.36 ± 3.11),(23.65 ± 3.21) and (16.75 ± 1.89) μmol/L,separately] (t =24.17,P < 0.01; t =13.73,P < 0.01; t =4.89,P < 0.01).Serum levels of ALB in TACE group on the day after surgery,one week since surgery,4 weeks since surgery were (33.54 ± 3.56),(30.74±3.12) and (32.78±4.11) g/L,and were significantly lower than them in TASCE group[(37.67 ±5.34),(36.95±3.60) and (38.23±3.68)g/L,separately](t =-4.06,P<0.01; t =-8.24,P<0.01; t =-6.25,P<0.01).In the type of tumor with morphology of dense iodine oil,rate of tumor shrinkage in TASCE group(86.36%) was significantly higher than TACE group(50.00%) (x2=5.96,P<0.05).Conclusions In clinical treatment for primary liver cancer,clinical effects and hepatoprotection of TASCE group are hbtter than TACE group. Key words: Liver neoplasms; Hepatitis B; Transcatheter arterial segmental chemoembolization; Transcatheter arterial chemoembolization

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call